These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27602580)

  • 1. Correlation between positron emission tomography and Cerenkov luminescence imaging in vivo and ex vivo using 64Cu-labeled antibodies in a neuroblastoma mouse model.
    Maier FC; Schmitt J; Maurer A; Ehrlichmann W; Reischl G; Nikolaou K; Handgretinger R; Pichler BJ; Thaiss WM
    Oncotarget; 2016 Oct; 7(41):67403-67411. PubMed ID: 27602580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immuno-Cerenkov luminescence and -PET imaging enables detection of PSMA
    Maier FC; Wild AM; Kirchen N; Holm F; Fuchs K; Schwenck J; Maurer A; Wiehr S
    Appl Radiat Isot; 2019 Jan; 143():149-155. PubMed ID: 30445280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.
    D'Souza JW; Hensley H; Doss M; Beigarten C; Torgov M; Olafsen T; Yu JQ; Robinson MK
    J Nucl Med; 2017 Jan; 58(1):175-180. PubMed ID: 27539844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerenkov luminescence imaging of medical isotopes.
    Ruggiero A; Holland JP; Lewis JS; Grimm J
    J Nucl Med; 2010 Jul; 51(7):1123-30. PubMed ID: 20554722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.
    Timmermand OV; Tran TA; Strand SE; Axelsson J
    J Nucl Med; 2015 Mar; 56(3):444-9. PubMed ID: 25655628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 89Zr-rituximab tracer by Cerenkov luminescence imaging and correlation with PET in a humanized transgenic mouse model to image NHL.
    Natarajan A; Habte F; Liu H; Sathirachinda A; Hu X; Cheng Z; Nagamine CM; Gambhir SS
    Mol Imaging Biol; 2013 Aug; 15(4):468-75. PubMed ID: 23471750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerenkov Luminescence Imaging (CLI) for cancer therapy monitoring.
    Xu Y; Liu H; Chang E; Jiang H; Cheng Z
    J Vis Exp; 2012 Nov; (69):e4341. PubMed ID: 23183774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma.
    Fan D; Zhang X; Zhong L; Liu X; Sun Y; Zhao H; Jia B; Liu Z; Zhu Z; Shi J; Wang F
    Bioconjug Chem; 2015 Jun; 26(6):1054-60. PubMed ID: 25853280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal imaging with (18)F-FDG PET and Cerenkov luminescence imaging after MLN4924 treatment in a human lymphoma xenograft model.
    Robertson R; Germanos MS; Manfredi MG; Smith PG; Silva MD
    J Nucl Med; 2011 Nov; 52(11):1764-9. PubMed ID: 21994410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Cerenkov Luminescence Imaging (CLI) Comparable With 3-D PET Standard Measurements.
    Habte F; Natarajan A; Paik DS; Gambhir SS
    Mol Imaging; 2018; 17():1536012118788637. PubMed ID: 30043654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proof-of-concept study of monitoring cancer drug therapy with cerenkov luminescence imaging.
    Xu Y; Chang E; Liu H; Jiang H; Gambhir SS; Cheng Z
    J Nucl Med; 2012 Feb; 53(2):312-317. PubMed ID: 22241909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerenkov Luminescence Imaging for Radiation Dose Calculation of a ⁹⁰Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
    Lohrmann C; Zhang H; Thorek DL; Desai P; Zanzonico PB; O'Donoghue J; Irwin CP; Reiner T; Grimm J; Weber WA
    J Nucl Med; 2015 May; 56(5):805-11. PubMed ID: 25840974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.
    Elsässer-Beile U; Reischl G; Wiehr S; Bühler P; Wolf P; Alt K; Shively J; Judenhofer MS; Machulla HJ; Pichler BJ
    J Nucl Med; 2009 Apr; 50(4):606-11. PubMed ID: 19289418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 64Cu-p-NH2-Bn-DOTA-hu14.18K322A, a PET radiotracer targeting neuroblastoma and melanoma.
    Vavere AL; Butch ER; Dearling JL; Packard AB; Navid F; Shulkin BL; Barfield RC; Snyder SE
    J Nucl Med; 2012 Nov; 53(11):1772-8. PubMed ID: 23064212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions.
    Holland JP; Normand G; Ruggiero A; Lewis JS; Grimm J
    Mol Imaging; 2011 Jun; 10(3):177-86, 1-3. PubMed ID: 21496448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.
    Luo H; England CG; Graves SA; Sun H; Liu G; Nickles RJ; Cai W
    J Nucl Med; 2016 Feb; 57(2):285-90. PubMed ID: 26541778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ lymphoma imaging in a spontaneous mouse model using the Cerenkov Luminescence of F-18 and Ga-67 isotopes.
    Ritter Z; Zámbó K; Balogh P; Szöllősi D; Jia X; Balázs Á; Taba G; Dezső D; Horváth I; Alizadeh H; Tuch D; Vyas K; Hegedűs N; Kovács T; Szigeti K; Máthé D; Schmidt E
    Sci Rep; 2021 Dec; 11(1):24002. PubMed ID: 34907289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ionic charge of copper-64 complexes conjugated to an engineered antibody affects biodistribution.
    Dearling JL; Paterson BM; Akurathi V; Betanzos-Lara S; Treves ST; Voss SD; White JM; Huston JS; Smith SV; Donnelly PS; Packard AB
    Bioconjug Chem; 2015 Apr; 26(4):707-17. PubMed ID: 25719414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsically radioactive [64Cu]CuInS/ZnS quantum dots for PET and optical imaging: improved radiochemical stability and controllable Cerenkov luminescence.
    Guo W; Sun X; Jacobson O; Yan X; Min K; Srivatsan A; Niu G; Kiesewetter DO; Chang J; Chen X
    ACS Nano; 2015 Jan; 9(1):488-95. PubMed ID: 25549258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.